GMO strengthens equities line-up
Global investment management firm GMO has appointed three senior investment professionals to its Sydney-based Australian equities team.
Geoff Wells, Mark Thompson and Bradley Grehan are intended to “strengthen GMO’s global portfolio management, research and trading efforts”, according to GMO’s head of Australian equities Rick Suvak.
Formerly a senior portfolio manager at Macquarie Investment Management, Wells has been appointed as a senior quantitative research analyst, focusing primarily on alpha model research.
Thompson has also joined GMO as senior quantitative research analyst, and will also be concentrating on alpha model research.
He was previously a quantitative portfolio manager at State Street Global Advisors where he managed the group’s short enabled strategies (market-neutral, equitised long-short and 130/30 portfolios).
Grehan joins GMO as a senior portfolio trader, and will focus on trade execution while also participating in the management of GMO’s Australian equity portfolios.
He brings 12 years of industry and trading experience to GMO from Tolhurst, Morgan Stanley and JBWere.
Recommended for you
Grant Hackett has been promoted from CEO of Generation Life to head up the wider Generation Development Group.
Tribeca Investment Partners has made a distribution hire from Australian Ethical in a newly-created role focused on the national intermediary market.
Asset managers may be urged to diversify their product ranges, but investment executives have warned any M&A deal should avoid simply filling gaps and instead consider long-term value creation.
Specialist wealth platform provider Mason Stevens has become the latest target of an acquisition as it enters a binding agreement with a leading Sydney-based private equity firm.
